Moving targets: COVID-19 vaccine efficacy against Omicron subvariants

Mol Ther. 2022 Aug 3;30(8):2644-2645. doi: 10.1016/j.ymthe.2022.07.004. Epub 2022 Jul 31.

Authors

Maria Karolaynne da Silva¹, Umberto Laino Fulco¹, Edilson Dantas da Silva Júnior¹, Jonas Ivan Nobre Oliveira²

Affiliations

¹ Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, 59078-900, Natal/RN, Brazil.
² Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, 59078-900, Natal/RN, Brazil. Electronic address: jonasivan@gmail.com.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Vaccine Efficacy

Substances

COVID-19 Vaccines